Who Paid My Doc
Shamaila Aslam
Internal Medicine Tomball, TX Medical Doctor
NPI 1992748545 CMS profile 363076
308 Holderrieth Blvd, Tomball, TX 77375
General payments
$10,506
Research payments
$9,704
Ownership & investment interest
$0
Research they led as principal investigator
$7,492,578
Through program year 2025, Shamaila Aslam of Tomball, TX is reported in the CMS Open Payments database as having received $10,506 across 85 general payments and $9,704 in research payments paid to them. Separately, studies naming them as principal investigator received $7,492,578 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 97th percentile of Internal Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
13 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $239 | 4 | |
| 2024 | General | $1,039 | 8 | |
| 2024 | Research | $1,654 | 1 | |
| 2023 | General | $983 | 10 | |
| 2023 | Research | $910 | 2 | |
| 2022 | General | $2,869 | 17 | |
| 2022 | Research | $447 | 1 | |
| 2021 | General | $61 | 4 | |
| 2021 | Research | $4,967 | 3 | |
| 2020 | General | $667 | 8 | |
| 2020 | Research | $836 | 1 | |
| 2019 | General | $4,649 | 34 | |
| 2019 | Research | $889 | 7 |
Beside peers
- Shamaila Aslam
- Internal Medicine median
- Middle half of Internal Medicine
- National median
In program year 2025, general payments to Shamaila Aslam were reported at $239. Among 52,115 Internal Medicine profiles paid that year, the median was $156 and the middle half received between $47 and $551.
Show as a table
| Year | Shamaila Aslam | Internal Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $4,649 | $159 | $48–$570 | $163 |
| 2020 | $667 | $119 | $33–$402 | $114 |
| 2021 | $61 | $135 | $37–$521 | $132 |
| 2022 | $2,869 | $141 | $42–$496 | $149 |
| 2023 | $983 | $149 | $45–$519 | $160 |
| 2024 | $1,039 | $154 | $47–$537 | $164 |
| 2025 | $239 | $156 | $47–$551 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
100 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Internal Medicine in Texas
Related records
Internal Medicine in Texas
Practitioners in the same specialty and state, ranked by reported value.
All Internal Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Texas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.